Eli Lilly (LLY) to acquire AtaiBeckley (ATAI) to advance therapies for treatment-resistant depression and other mental health conditions; deal value at USD 6.75/shr upfront
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ELI LILLY & CO#LLY.US#ATA INC/CHINA#ATAI.US#FOREX#EQUITIES#METALS#EU SESSION#PHARMACEUTICALS#METALS & MINING#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#DXY#US EQUITIES